This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Momenta Pharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
Other definitive proxy statements - April 22, 2014